Related Experiment Video

Updated: Jun 2, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

[Treatment of advanced metastatic melanoma]

S Ugurel1, J C Becker

  • 1Allgemeine Dermatologie, Medizinische Universität Graz, Österreich.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|May 3, 2011
PubMed

Insights

Advanced melanoma treatment has improved with new targeted and immune therapies. This review discusses these novel options alongside traditional treatments like radiation and chemotherapy for better patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Context:

  • Advanced melanoma with distant metastases historically had poor therapeutic success.
  • Recent advancements in understanding melanoma pathogenesis and tumor immunology are crucial.
  • Identification of specific patient subgroups benefiting from novel therapies.

Purpose:

  • To review emerging molecular-targeted and immune-modulating therapies for advanced melanoma.
  • To discuss the role of established treatments like radiation and chemotherapy.
  • To provide an overview of current therapeutic strategies for melanoma patients.

Summary:

  • Novel therapeutic options have been developed for specific melanoma patient subgroups.
  • Molecular-targeted therapies and immune-modulating agents represent significant progress.
  • Established treatments including radiation and chemotherapy remain relevant.

Impact:

  • Improved treatment paradigms for advanced melanoma.
  • Enhanced understanding of melanoma pathogenesis and immunology.
  • Potential for better patient outcomes through personalized therapeutic approaches.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver09:02

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...